These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of Paliperidone Palmitate Throughout a Schizoaffective Disorder Patient's Gestation Period. Zamora Rodríguez FJ; Benítez Vega C; Sánchez-Waisen Hernández MR; Guisado Macías JA; Vaz Leal FJ Pharmacopsychiatry; 2017 Jan; 50(1):38-40. PubMed ID: 27414740 [No Abstract] [Full Text] [Related]
23. Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia. Saitis M; Papazisis G; Katsigiannopoulos K; Kouvelas D Psychiatry Clin Neurosci; 2008 Oct; 62(5):624. PubMed ID: 18950388 [No Abstract] [Full Text] [Related]
24. Estimated medical cost reductions for paliperidone palmitate vs placebo in a randomized, double-blind relapse-prevention trial of patients with schizoaffective disorder. Joshi K; Lin J; Lingohr-Smith M; Fu DJ J Med Econ; 2015; 18(8):629-36. PubMed ID: 25800457 [TBL] [Abstract][Full Text] [Related]
25. Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone. Zaidi AN Ann Pharmacother; 2005 Oct; 39(10):1726-31. PubMed ID: 16131536 [TBL] [Abstract][Full Text] [Related]
27. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease? Oechsner M; Korchounov A Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011 [TBL] [Abstract][Full Text] [Related]
30. Focus on ziprasidone. Green B Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185 [TBL] [Abstract][Full Text] [Related]
31. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone. Scahill L; Blair J; Leckman JF; Martin A J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441 [No Abstract] [Full Text] [Related]
32. A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder. Das P J Clin Psychopharmacol; 2016 Aug; 36(4):393-4. PubMed ID: 27281388 [No Abstract] [Full Text] [Related]
33. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation. Mauri MC; Reggiori A; Paletta S; Di Pace C; Altamura AC Expert Opin Drug Saf; 2017 Mar; 16(3):365-379. PubMed ID: 28140680 [TBL] [Abstract][Full Text] [Related]
34. A case report with ziprasidone-induced catatonic symptoms. Markham-Abedi C; McNeely C; de Leon J J Neuropsychiatry Clin Neurosci; 2007; 19(4):476-7. PubMed ID: 18070860 [No Abstract] [Full Text] [Related]
35. [Rhabdomyolysis induced by paliperidone palmitate]. Klein B; Silberbauer C Neuropsychiatr; 2021 Jun; 35(2):98-101. PubMed ID: 33242202 [TBL] [Abstract][Full Text] [Related]
36. Drugs for psychotic disorders. Med Lett Drugs Ther; 2016 Dec; 58(1510):160-164. PubMed ID: 27960194 [No Abstract] [Full Text] [Related]
37. Possible ziprasidone-induced mania. Larson MF; Hauser A J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565 [No Abstract] [Full Text] [Related]
39. Tardive dystonia associated with ziprasidone. Papapetropoulos S; Wheeler S; Singer C Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868 [No Abstract] [Full Text] [Related]
40. Lithium carbonate as a treatment for paliperidone extended-release-induced leukopenia and neutropenia in a patient with schizoaffective disorder; a case report. Matsuura H; Kimoto S; Harada I; Naemura S; Yamamuro K; Kishimoto T BMC Psychiatry; 2016 May; 16():161. PubMed ID: 27229149 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]